5Stewart JT,Warren FW,Maddox FC,et al.The stability of remifentanil hydrochloride and propofol in polypropylene syringes and polyvinylchloride bags at 22-24℃.Anesth Analg,2000,90:1450-1451. 被引量：1
6Hindmarch I.Psychomotor function and psychoactive drugs.Br J Clin Pharmacol,1980,10:189-209. 被引量：1
7Joo HS,Perks WJ,Kataoka MT,et al.A comparison of patient-controlled sedation using either remifentanil or remifentanilpropofol for shock wave lithotripsy.Anesth Analg,2001,93:1227-1232. 被引量：1
8Davis PJ,Finkel JC,Orr RJ,et al.A randomized,double-blinded study of remifentanil versus fentanyl for tonsillectomy and adenoidectomy surgery in pediatric ambulatory surgical patients.Anesth Analg,2000,90:863-871. 被引量：1
9Glass PSA,Hardman D,Kamiyama Y,et al.A review of thepharmacokinctics and phamacodynamics of remifentanil.Anesth Analg,1999,89(Suppl 4):7-14. 被引量：1
10Brockmann C,Raasch W,Bastian C,et al.Endocrine stress parameters during TIVA with remifentanil or sufentanil.Anesth Int Not Schm,2000,35:685-691. 被引量：1
